News & Discoveries

November 10, 2022

UCSF Experts to Highlight Cutting Edge Advances and Discoveries at World’s Largest Meeting Devoted to NeuroscienceBrain implants for speech, neurological effects of COVID-19, and motor recovery after stroke are among the topics that researchers from UCSF will be presenting at this year’s annual meeting of the Society for Neuroscience.

November 01, 2022

UCSF Researchers Drive Efforts to Recruit More Black, Latinx, Asian and American Indian ParticipantsA $147 million grant will expand diversity among Alzheimer’s disease research participants, and involve partners from UCSF, the San Francisco VA Medical Center, and the Northern California Institute for Research and Education.

October 27, 2022

After Don Onken suffered a stroke at 78, a quick response by doctors at the UCSF Medical Center at Parnassus Heights helped him get back on his feet quickly – and back to the golf course.

October 17, 2022

UCSF Researchers Rescue Cognitive Function by Blocking Molecular Stress Response with ISRIBA small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.

October 03, 2022

Diverse Digital Interventions Remediate Cognitive Aging in Healthy Older AdultsAfter a decade of work, scientists at UCSF’s Neuroscape Center have developed a suite of video game interventions that improve key aspects of cognition in aging adults.

October 03, 2022

Treatment Depends on Amyloid Plaques, but UCSF-Vanderbilt Led Study Shows Lower Incidence in MinoritiesA new study shows that fewer Black, Hispanic and Asian patients would qualify for these treatments that may slow Alzheimer’s progression, since cognitive impairment in these groups is more likely to be caused by other forms of dementia that may be unrelated to amyloid plaques.

September 30, 2022

New Molecules Are Lead Candidates for Alternative to Narcotics, Say UCSF ResearchersA newly identified set of molecules alleviated pain in mice while avoiding the sedating affect that limits the use of opiates, according to a new study led by researchers at UC San Francisco.

September 29, 2022

Findings Open Door to Precision Therapeutics for Neonatal HemorrhageUCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.

September 28, 2022

Designer Molecules Activate Select Pathway of the Psychedelic Receptor 5HT2aScientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.

September 26, 2022

UCSF-Led Study Suggests Model May Lead to Fewer Unnecessary Medical InterventionsA mortality prediction model for older adults with dementia may help physicians determine which treatments to provide while facilitating decision-making for patients and their families.

Pages